Literature DB >> 16177307

Alteration in host cell tropism limits the efficacy of immunization with a surface protein of malaria merozoites.

Qifang Shi1, Amy Cernetich, Thomas M Daly, Gina Galvan, Akhil B Vaidya, Lawrence W Bergman, James M Burns.   

Abstract

Immunization with Plasmodium yoelii merozoite surface protein-8 (PyMSP-8) has been shown to protect mice against lethal P. yoelii 17XL malaria. Here we demonstrate that PyMSP-8-specific antibodies preferentially suppress P. yoelii 17XL growth in mature erythrocytes compared to growth in reticulocytes and do not suppress the growth of nonlethal P. yoelii 17X, a parasite that primarily replicates in reticulocytes. The protection against normocyte-associated P. yoelii malaria parasites is mediated by antibodies that recognize conformational epitopes of PyMSP-8 that are nonpolymorphic. We examined changes in gene expression in reticulocyte-restricted P. yoelii 17XL parasites that escaped neutralization by PyMSP-8-specific antibodies using P. yoelii DNA microarrays. Of interest, Pymsp-8 gene expression decreased, while the expression of msp-1, msp-7, and several rhoptry protein genes increased. Breakthrough parasites also exhibited increases in the expression of a subset of yir and Pyst-a genes that are predicted to encode polymorphic antigens expressed on the surface of infected erythrocytes. These data suggest that changes in the expression of parasite proteins expressed on the merozoite surface, as well as the surface of infected erythrocytes, may alter host cell tropism and contribute to the ability of malaria parasites to evade merozoite-specific, neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16177307      PMCID: PMC1230925          DOI: 10.1128/IAI.73.10.6363-6371.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  Merozoite antigens involved in invasion.

Authors:  Klavs Berzins
Journal:  Chem Immunol       Date:  2002

2.  A large gene family for putative variant antigens shared by human and rodent malaria parasites.

Authors:  Christoph S Janssen; Michael P Barrett; C Michael R Turner; R Stephen Phillips
Journal:  Proc Biol Sci       Date:  2002-02-22       Impact factor: 5.349

3.  Merozoite surface protein 8 of Plasmodium falciparum contains two epidermal growth factor-like domains.

Authors:  C G Black; T Wu; L Wang; A R Hibbs; R L Coppel
Journal:  Mol Biochem Parasitol       Date:  2001-05       Impact factor: 1.759

4.  A superfamily of variant genes encoded in the subtelomeric region of Plasmodium vivax.

Authors:  H A del Portillo; C Fernandez-Becerra; S Bowman; K Oliver; M Preuss; C P Sanchez; N K Schneider; J M Villalobos; M A Rajandream; D Harris; L H Pereira da Silva; B Barrell; M Lanzer
Journal:  Nature       Date:  2001-04-12       Impact factor: 49.962

5.  Specificity of the protective antibody response to apical membrane antigen 1.

Authors:  A N Hodder; P E Crewther; R F Anders
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

6.  Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli.

Authors:  Sheetij Dutta; P V Lalitha; Lisa A Ware; Arnoldo Barbosa; J Kathleen Moch; Meredith A Vassell; Bader B Fileta; Svetlana Kitov; Nelly Kolodny; D Gray Heppner; J David Haynes; David E Lanar
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  Plasmodium yoelii uses the murine Duffy antigen receptor for chemokines as a receptor for normocyte invasion and an alternative receptor for reticulocyte invasion.

Authors:  Christine J Swardson-Olver; Tracey C Dawson; Robert C Burnett; Stephen C Peiper; Nobuyo Maeda; Anne C Avery
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

Review 8.  The pathogenic basis of malaria.

Authors:  Louis H Miller; Dror I Baruch; Kevin Marsh; Ogobara K Doumbo
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

9.  The 22 kDa component of the protein complex on the surface of Plasmodium falciparum merozoites is derived from a larger precursor, merozoite surface protein 7.

Authors:  J A Pachebat; I T Ling; M Grainger; C Trucco; S Howell; D Fernandez-Reyes; R Gunaratne; A A Holder
Journal:  Mol Biochem Parasitol       Date:  2001-09-28       Impact factor: 1.759

10.  Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.

Authors:  R A O'Donnell; T F de Koning-Ward; R A Burt; M Bockarie; J C Reeder; A F Cowman; B S Crabb
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

View more
  11 in total

1.  Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection.

Authors:  James R Alaro; Michele M Lynch; James M Burns
Journal:  Vaccine       Date:  2010-08-13       Impact factor: 3.641

2.  High mobility group protein HMGB2 is a critical regulator of plasmodium oocyst development.

Authors:  Mathieu Gissot; Li-Min Ting; Thomas M Daly; Lawrence W Bergman; Photini Sinnis; Kami Kim
Journal:  J Biol Chem       Date:  2008-04-08       Impact factor: 5.157

3.  A chimeric Plasmodium falciparum merozoite surface protein vaccine induces high titers of parasite growth inhibitory antibodies.

Authors:  James R Alaro; Andrea Partridge; Kazutoyo Miura; Ababacar Diouf; Ana M Lopez; Evelina Angov; Carole A Long; James M Burns
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

4.  Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant Pfs25, a Leading Transmission-Blocking Vaccine Candidate.

Authors:  Elizabeth M Parzych; Kazutoyo Miura; Aarti Ramanathan; Carole A Long; James M Burns
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

5.  Evaluation of the immunogenicity and vaccine potential of recombinant Plasmodium falciparum merozoite surface protein 8.

Authors:  James R Alaro; Evelina Angov; Ana M Lopez; Hong Zhou; Carole A Long; James M Burns
Journal:  Infect Immun       Date:  2012-05-14       Impact factor: 3.441

6.  Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.

Authors:  Qifang Shi; Michelle M Lynch; Margarita Romero; James M Burns
Journal:  Infect Immun       Date:  2006-12-11       Impact factor: 3.441

7.  Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections.

Authors:  Lorena Martin-Jaular; Ernesto S Nakayasu; Mireia Ferrer; Igor C Almeida; Hernando A Del Portillo
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

8.  Remarkable stability in patterns of blood-stage gene expression during episodes of non-lethal Plasmodium yoelii malaria.

Authors:  Amy Cernetich-Ott; Thomas M Daly; Akhil B Vaidya; Lawrence W Bergman; James M Burns
Journal:  Malar J       Date:  2012-08-06       Impact factor: 2.979

9.  The role of serine-type serine repeat antigen in Plasmodium yoelii blood stage development.

Authors:  Ximei Huang; Kingsley Liew; Onguma Natalang; Anthony Siau; Neng Zhang; Peter Rainer Preiser
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

10.  A genetically hard-wired metabolic transcriptome in Plasmodium falciparum fails to mount protective responses to lethal antifolates.

Authors:  Karthikeyan Ganesan; Napawan Ponmee; Lei Jiang; Joseph W Fowble; John White; Sumalee Kamchonwongpaisan; Yongyuth Yuthavong; Prapon Wilairat; Pradipsinh K Rathod
Journal:  PLoS Pathog       Date:  2008-11-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.